Insider Trading & Ownership - Coyne Terrance P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Coyne Terrance P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-08-09
Sale
2023-08-11
5:00 pm
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
75,000$30.73$2,305,028840,390
(Indirect
Direct)
View
2023-07-12
Sale
2023-07-14
6:09 pm
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
75,000$31$2,325,214915,390
(Indirect
Direct)
View
2022-11-08
Sale
2022-11-10
5:04 pm
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
24,500$43.47$1,065,013990,390
(Indirect
Direct)
View
2022-11-02
Sale
2022-11-04
7:16 pm
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
5,500$43.06$236,8461,014,890
(Indirect
Direct)
View
2022-08-01
Sale
2022-08-03
7:12 pm
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
30,000$43.19$1,295,7271,020,390
(Indirect
Direct)
View
2021-03-03
Sale
2021-03-05
7:04 pm
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
100,000$44.78$4,478,450250,390
(Indirect
Direct)
View
2021-03-02
Sale
2021-03-04
7:00 pm
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
100,000$46.94$4,694,090350,390
(Indirect
Direct)
View
2020-06-18
Purchase
2020-06-23
9:21 pm
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
2,950$28$82,600797,705
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-12
Gift
2024-08-12
7:20 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
2,000$0349,350
(Indirect)
View
2023-08-08
Gift
2023-08-08
5:37 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
1,650$0351,350
(Indirect)
View
2021-05-07
Conversion
2021-05-11
9:05 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
1,100,000$01,346,858
(Indirect)
View
2020-12-31
Conversion
2021-01-05
9:53 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
440,000$0827,636
(Indirect)
View
2020-06-15
Option Award(A)
2021-01-05
9:51 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
2,605$026,963
(Indirect)
View
2020-06-18
Conversion(A)
2021-01-05
9:51 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
26,587$026,963
(Indirect)
View

Ownership(A)
2021-01-05
9:49 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
0$026,050
(Indirect)
View
2020-06-15
Option Award
2020-06-23
9:21 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
772,754$0797,705
(Indirect)
View
2020-06-18
Conversion
2020-06-23
9:21 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
25,597$0797,705
(Indirect)
View

Ownership(A)
2020-06-17
8:51 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
0$048,000
(Direct)
View

Ownership
2020-06-15
9:27 pm
N/A
N/A
Royalty Pharma plcRPRXCoyne Terrance P.
EVP & CFO
0$04,502,540
(Indirect)
View
(A) Indicate amendment filing.